Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease

Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease

US Patent 8852650 · Granted Oct 7, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual AAV-MYO7A vectors with improved safety for the treatment of USH1B2025
Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degener2011
Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degener2011
Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degener2011
Method and apparatus for reading and writing pixel-aligned subframes in a frame 2009
Use of Bowman Birk inhibitor for the treatment of multiple sclerosis and other a2007
Use of bowman birk inhibitor for the treatment of multiple sclerosis and other a2004
Use of insulin-like growth factor-I in muscle2004
Bowman-birk inhibitor compositions and methods for the treatment of genitourinar1999
Method of monitoring exposure to Bowman Birk inhibitor using monoclonal antibodi1997
Monoclonal antibodies differentially reactive with native and reductively modifi1997
Bowman-Birk Inhibitor compositions for treatment of inflammatory disease1997